Literature DB >> 18682255

Arsenic metabolism is influenced by polymorphisms in genes involved in one-carbon metabolism and reduction reactions.

Karin Schläwicke Engström1, Barbro Nermell, Gabriela Concha, Ulf Strömberg, Marie Vahter, Karin Broberg.   

Abstract

OBJECTIVES: The susceptibility to arsenic (As)-induced diseases differs greatly between individuals, probably to a large extent due to genetic differences in arsenic metabolism. The aim for this study was to identify genetic variants affecting arsenic metabolism.
METHODS: We evaluated the association between urinary metabolite pattern and polymorphisms in three gene-groups related to arsenic metabolism: (1) methyltransferases, (2) other genes involved in one-carbon metabolism and (3) genes involved in reduction reactions. Forty-nine polymorphisms were successfully genotyped in indigenous women (N=104) from northern Argentina, exposed to approximately 200 microg/L of arsenic in drinking water, with a unique metabolism with low percent monomethylated arsenic (%MMA) and high percent dimethylated As (%DMA).
RESULTS: Genetic factors affecting arsenic metabolite pattern included two polymorphisms in arsenic (+III) methyltransferase (AS3MT) (rs3740400, rs7085104), where carriers had lower %MMA and higher %DMA. These single nucleotide polymorphisms (SNPs) were in strong linkage disequilibrium (LD) with three intronic AS3MT SNPs, previously reported to be associated with arsenic metabolism, indicating the existence of a strongly methylating, population-specific haplotype. The CYP17A1 rs743572, 27kilobasepairs (kbs) upstream of AS3MT, was in strong LD with the AS3MT SNPs and thus had similar effects on the metabolite profile. Smaller effects were also seen for one-carbon metabolism genes choline dehydrogenase (CHDH) (rs9001, rs7626693) and 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR) (rs1801394) and genes involved in reduction reactions, glutaredoxin (GLRX) (rs3822751) and peroxiredoxin 2 (PRDX2) (rs10427027, rs12151144). Genotypes associated with more beneficial arsenic metabolite profile (low %MMA and/or high %DMA in urine) were more common in this population, which has been exposed to arsenic in drinking water for thousands of years.
CONCLUSIONS: Polymorphisms in AS3MT and in genes involved in one-carbon metabolism and reduction reactions affects arsenic metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682255     DOI: 10.1016/j.mrfmmm.2008.07.003

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  42 in total

1.  Interactive Influence of N6AMT1 and As3MT Genetic Variations on Arsenic Metabolism in the Population of Inner Mongolia, China.

Authors:  Xushen Chen; Xiaojuan Guo; Ping He; Jing Nie; Xiaoyan Yan; Jinqiu Zhu; Luoping Zhang; Guangyun Mao; Hongmei Wu; Zhiyue Liu; Diana Aga; Peilin Xu; Martyn Smith; Xuefeng Ren
Journal:  Toxicol Sci       Date:  2016-09-16       Impact factor: 4.849

2.  Analysis of maternal polymorphisms in arsenic (+3 oxidation state)-methyltransferase AS3MT and fetal sex in relation to arsenic metabolism and infant birth outcomes: Implications for risk analysis.

Authors:  Zuzana Drobná; Elizabeth Martin; Kyung Su Kim; Lisa Smeester; Paige Bommarito; Marisela Rubio-Andrade; Gonzalo G García-Vargas; Miroslav Stýblo; Fei Zou; Rebecca C Fry
Journal:  Reprod Toxicol       Date:  2016-02-27       Impact factor: 3.143

3.  Low-level arsenic exposure via drinking water consumption and female fecundity - A preliminary investigation.

Authors:  Michele L Susko; Michael S Bloom; Iulia A Neamtiu; Allison A Appleton; Simona Surdu; Cristian Pop; Edward F Fitzgerald; Doru Anastasiu; Eugen S Gurzau
Journal:  Environ Res       Date:  2017-01-03       Impact factor: 6.498

4.  Polymorphisms of peroxiredoxin 1, 2 and 6 are not associated with esophageal cancer.

Authors:  Bo Zhang; Kai Wang; Gang He; Xinying Guan; Botao Liu; Yangbo Liu; Yun Bai
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-04       Impact factor: 4.553

Review 5.  Arsenic exposure in Latin America: biomarkers, risk assessments and related health effects.

Authors:  Tyler R McClintock; Yu Chen; Jochen Bundschuh; John T Oliver; Julio Navoni; Valentina Olmos; Edda Villaamil Lepori; Habibul Ahsan; Faruque Parvez
Journal:  Sci Total Environ       Date:  2011-11-26       Impact factor: 7.963

6.  Arsenic, one carbon metabolism and diabetes-related outcomes in the Strong Heart Family Study.

Authors:  Miranda J Spratlen; Maria Grau-Perez; Jason G Umans; Joseph Yracheta; Lyle G Best; Kevin Francesconi; Walter Goessler; Poojitha Balakrishnan; Shelley A Cole; Mary V Gamble; Barbara V Howard; Ana Navas-Acien
Journal:  Environ Int       Date:  2018-10-12       Impact factor: 9.621

7.  Genetic association between intronic variants in AS3MT and arsenic methylation efficiency is focused on a large linkage disequilibrium cluster in chromosome 10.

Authors:  Paulina Gomez-Rubio; Maria M Meza-Montenegro; Ernesto Cantu-Soto; Walter T Klimecki
Journal:  J Appl Toxicol       Date:  2010-04       Impact factor: 3.446

8.  Requirement of arsenic biomethylation for oxidative DNA damage.

Authors:  Chikara Kojima; Dario C Ramirez; Erik J Tokar; Seiichiro Himeno; Zuzana Drobná; Miroslav Stýblo; Ronald P Mason; Michael P Waalkes
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 13.506

9.  Polymorphisms in maternal folate pathway genes interact with arsenic in drinking water to influence risk of myelomeningocele.

Authors:  Maitreyi Mazumdar; Linda Valeri; Ema G Rodrigues; Md Omar Sharif Ibne Hasan; Rezina Hamid; Ligi Paul; Jacob Selhub; Fareesa Silva; Md Golam Mostofa; Quazi Quamruzzaman; Mahmuder Rahman; David C Christiani
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-08-06

10.  Differential metabolism of inorganic arsenic in mice from genetically diverse Collaborative Cross strains.

Authors:  Miroslav Stýblo; Christelle Douillet; Jacqueline Bangma; Lauren A Eaves; Fernando Pardo-Manuel de Villena; Rebecca Fry
Journal:  Arch Toxicol       Date:  2019-09-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.